posted on 2022-02-17, 00:44authored byCarly
K. Schissel, Charlotte E. Farquhar, Annika B. Malmberg, Andrei Loas, Bradley L. Pentelute
Cell-penetrating
peptides (CPPs) can cross the cell membrane to
enter the cytosol and deliver otherwise nonpenetrant macromolecules
such as proteins and oligonucleotides. For example, recent clinical
trials have shown that a CPP attached to phosphorodiamidate morpholino
oligomers (PMOs) resulted in higher muscle concentration, increased
exon skipping, and dystrophin production relative to another study
of the PMO alone in patients of Duchenne muscular dystrophy. Therefore,
effective design and the study of CPPs could help enhance therapies
for difficult-to-treat diseases. So far, the study of CPPs for PMO
delivery has been restricted to predominantly canonical l-peptides. We hypothesized that mirror-image d-peptides
could have similar PMO delivery activity as well as enhanced proteolytic
stability, facilitating their characterization and quantification
from biological milieu. We found that several enantiomeric peptide
sequences could deliver a PMO–biotin cargo with similar activities
while remaining stable against serum proteolysis. The biotin label
allowed for affinity capture of fully intact PMO–peptide conjugates
from whole-cell and cytosolic lysates. By profiling a mixture of these
constructs in cells, we determined their relative intracellular concentrations.
When combined with PMO activity, these concentrations provide a new
metric for delivery efficiency, which may be useful for determining
which peptide sequence to pursue in further preclinical studies.